165 related articles for article (PubMed ID: 17277075)
1. Thiopurines, DNA damage, DNA repair and therapy-related cancer.
Karran P
Br Med Bull; 2006; 79-80():153-70. PubMed ID: 17277075
[TBL] [Abstract][Full Text] [Related]
2. Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.
Karran P; Attard N
Nat Rev Cancer; 2008 Jan; 8(1):24-36. PubMed ID: 18097462
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
4. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair and response to DNA-damaging antitumour therapies.
Bignami M; Casorelli I; Karran P
Eur J Cancer; 2003 Oct; 39(15):2142-9. PubMed ID: 14522371
[TBL] [Abstract][Full Text] [Related]
6. Review article: thiopurines in inflammatory bowel disease.
Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
[TBL] [Abstract][Full Text] [Related]
7. Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.
Petit E; Langouet S; Akhdar H; Nicolas-Nicolaz C; Guillouzo A; Morel F
Toxicol In Vitro; 2008 Apr; 22(3):632-42. PubMed ID: 18222062
[TBL] [Abstract][Full Text] [Related]
8. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
[TBL] [Abstract][Full Text] [Related]
9. Combination of azathioprine and UVA irradiation is a major source of cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine.
Cooke MS; Duarte TL; Cooper D; Chen J; Nandagopal S; Evans MD
DNA Repair (Amst); 2008 Dec; 7(12):1982-9. PubMed ID: 18793759
[TBL] [Abstract][Full Text] [Related]
10. UVA photosensitization of thiopurines and skin cancer in organ transplant recipients.
Attard NR; Karran P
Photochem Photobiol Sci; 2012 Jan; 11(1):62-8. PubMed ID: 21860872
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
12. Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation.
Gueranger Q; Li F; Peacock M; Larnicol-Fery A; Brem R; Macpherson P; Egly JM; Karran P
J Invest Dermatol; 2014 May; 134(5):1408-1417. PubMed ID: 24284422
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy in childhood leukaemia: in vitro studies of thiopurines and inhibitors of purine metabolism on apoptosis.
De Abreu RA; Trueworthy RC; van Kuilenburg AB; Vogels-Mentink TM; Lambooy LH; van Gennip AH
Ann Clin Biochem; 2003 Jan; 40(Pt 1):70-4. PubMed ID: 12542913
[TBL] [Abstract][Full Text] [Related]
14. Ras-targeting action of thiopurines in the presence of reactive nitrogen species.
Heo J; Hong I
Biochemistry; 2010 May; 49(18):3965-76. PubMed ID: 20377193
[TBL] [Abstract][Full Text] [Related]
15. DNA repair: a double-edged sword.
Wei Q; Frazier ML; Levin B
J Natl Cancer Inst; 2000 Mar; 92(6):440-1. PubMed ID: 10716953
[No Abstract] [Full Text] [Related]
16. Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia.
Bulgar AD; Snell M; Donze JR; Kirkland EB; Li L; Yang S; Xu Y; Gerson SL; Liu L
Leukemia; 2010 Oct; 24(10):1795-9. PubMed ID: 20811400
[No Abstract] [Full Text] [Related]
17. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
18. Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?
Lopez A; Beaugerie L; Peyrin-Biroulet L
Expert Rev Clin Immunol; 2014 Dec; 10(12):1563-5. PubMed ID: 25362886
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
Sanderson J; Ansari A; Marinaki T; Duley J
Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
[TBL] [Abstract][Full Text] [Related]
20. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
